MAIA Biotechnology(MAIA) announced the Company has no exposure to Silicon Valley Bank (SIVB). The Company is aware that the Federal Deposit Insurance Corp. has taken control of SVB due to liquidity concerns. The Company confirms it does not hold any deposits or investments at SVB, as well as at Silvergate Bank (SI), or Signature Bank (SBNY). MAIA’s cash is managed across a top-tier financial institution.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MAIA:
- MAIA Biotechnology doses first two patients in THIO-101 trial
- MAIA Biotechnology initiated with an Outperform at Noble Capital
- MAIA :THIO combo with checkpoint immune therapies showed tumor inhibition
- MAIA Biotechnology files to sell 2.43M shares of common stock
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue